Clinical Trial: Diagnostic Study of a Combined Strategy Using AI-Assisted Multimodal Targeting and Optimized Systemic Needle Biopsy in Prostate Cancer (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diagnostic Study of a Combined Strategy Using AI-Assisted Multimodal Targeting and Optimized Systemic Needle Biopsy in Prostate Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131667

Registration Time: 2026/09/04

Type: Diagnostic test

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339824

Published by HT Digital Content Services with permission from Health Daily Digest....